(NASDAQ: PRTC) Puretech Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 56.18%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 102.16%.
Puretech Health's earnings in 2025 is $50,678,000.On average, 2 Wall Street analysts forecast PRTC's earnings for 2025 to be -$145,594,196, with the lowest PRTC earnings forecast at -$141,269,616, and the highest PRTC earnings forecast at -$151,360,303. On average, 2 Wall Street analysts forecast PRTC's earnings for 2026 to be -$157,727,046, with the lowest PRTC earnings forecast at -$153,042,084, and the highest PRTC earnings forecast at -$163,973,661.
In 2027, PRTC is forecast to generate -$167,433,326 in earnings, with the lowest earnings forecast at -$162,460,058 and the highest earnings forecast at -$174,064,348.